DRUG THERAPY OF CARDIOVASCULAR DISEASES: DATA OF EVIDENCE-BASED MEDICINE AND CLINICAL PRACTICE

DRUG THERAPY OF CARDIOVASCULAR DISEASES: DATA OF EVIDENCE-BASED MEDICINE AND CLINICAL PRACTICE

Drug therapy of cardiovascular diseases: data of evidence-based medicine and clinical practice.

Bibliographic Details
Main Authors:	R. G. Oganov, S. Y. Martsevich
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2001-08-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2098

Similar Items

CARDIOVASCULAR EVENT RISK REDUCTION WITH MEDICINES: DATA OF EVIDENCE BASED MEDICINE AND RECOMMENDATIONS TO PRACTITIONERS
by: S. Y. Martsevich
Published: (2016-01-01)

IMPORTANCE OF THE EPIDEMIOLOGIC STUDIES AND EVIDENCE-BASED MEDICINE FOR CLINICAL PRACTICE
by: R. G. Oganov
Published: (2015-08-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
by: S. Y. Martsevich
Published: (2015-12-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE
by: S. Y. Martsevich
Published: (2015-12-01)

NEWS OF EVIDENCE-BASED MEDICINE: RESULTS OF THE IMPROVE-IT TRIAL AND THEIR IMPLICATIONS FOR CLINICAL PRACTICE
by: S. Yu. Martsevich
Published: (2015-09-01)

NEWS OF EVIDENCE-BASED MEDICINE: RESULTS OF THE IMPROVE-IT TRIAL AND THEIR IMPLICATIONS FOR CLINICAL PRACTICE
by: S. Yu. Martsevich
Published: (2015-09-01)

LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

PROLOG Study: decreasing cardiovascular disease risk in hypertensive patients by antihypertensive therapy
by: S. A. Shalnova, et al.
Published: (2005-08-01)

Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine
by: S. Yu. Martsevich
Published: (2020-05-01)

Clinical Trials Evaluating Drug Therapy: Types, Reliability of Results, Place in Modern Evidence-Based Medicine
by: S. Yu. Martsevich, et al.
Published: (2021-05-01)

Could evidence-based medicine results be reproduced in real-world clinical practice?
by: S. Yu. Martsevich, et al.
Published: (2008-06-01)

MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Principles of evidence-based medicine in drug therapy of circulatory diseases
by: B I Geltser, et al.
Published: (2003-04-01)

FAMILY MEDICINE — THE OPTIMAL APPROACH TO PREVENTION OF CARDIOVASCULAR AND OTHER NON-COMMUNICABLE DISEASES
by: N. V. Suslonova, et al.
Published: (2015-10-01)

ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW?
by: S. Y. Martsevich
Published: (2016-01-01)

Nitrate role in cardiovascular disease management: scientific evidence and clinical practice
by: S. R. Gilyarevsky
Published: (2007-06-01)

Prevention of cardiovascular diseases in Russia: successes, failures, prospects
by: R G Oganov
Published: (2004-06-01)

INDIVIDUAL PREVENTION OF CARDIOVASCULAR DISEASES. THE POSITION OF EUROPEAN CARDIOVASCULAR SOCIETIES
by: R. G. Oganov, et al.
Published: (2017-02-01)

How to solve the problem of drug choice within the same class from the standpoint of evidence-based medicine?
by: S. Yu. Martsevich
Published: (2019-05-01)

ROLE OF NIFEDIPIN IN CONTEMPORARY TREATMENT OF CARDIOVASCULAR DISEASES
by: S. Y. Martsevich
Published: (2000-12-01)

Experience in preventing cardiovascular diseases in our country
by: S A Boĭtsov, et al.
Published: (2012-09-01)

Understanding the gap between scientific evidence and clinical practice in cardiovascular diseases
by: Marta Patrícia Carvalho Viana
Published: (2019)

Demographic trends in the Russian Federation: the impact of cardiovascular disease
by: R. G. Oganov, et al.
Published: (2012-02-01)

SPECIFIC PROPERTIES OF THE DRUG THERAPY FOR STABLE ANGINA IN MEN
by: R. G. Oganov, et al.
Published: (2014-04-01)

THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR?
by: S. Yu. Martsevich
Published: (2016-01-01)

Complementary and Alternative Medicine and Cardiovascular Disease: An Evidence-Based Review
by: Matthew J. Rabito, et al.
Published: (2013-01-01)

Evidence-based medicine and the patient : the example of cardiovascular disease prevention
by: Marshall, Iain James
Published: (2016)

EVIDENCE-BASED MEDICINE AND CLINICAL PRACTICE IN PAKISTAN
by: Akhtar Sherin
Published: (2014-03-01)

Evidence-based medicine in equine clinical practice
by: Smith, Luisa J.
Published: (2006)

Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study
by: R. G. Oganov, et al.
Published: (2009-12-01)

Demographic situation and cardiovascular disease in Russia: problem scope and possible solutions
by: R. G. Oganov, et al.
Published: (1970-01-01)

Randomised Clinical Trials and Observational Studies: the Ratio in the Hierarchy of Evidence of the Efficacy of Drugs
by: S. Yu. Martsevich, et al.
Published: (2016-11-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT
by: S. Yu. Martsevich
Published: (2015-09-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT
by: S. Yu. Martsevich
Published: (2015-09-01)

CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA
by: S. Yu. Martsevich, et al.
Published: (2017-09-01)

Bisoprolol in cardiovascular disease treatment
by: S. N. Tolpygina, et al.
Published: (2008-12-01)

ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT?
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

ONCE AGAIN ABOUT THE HIERARCHY OF EVIDENCES IN MEDICINE OR WHETHER IT IS POSSIBLE TO CHOOSE THE MOST EFFECTIVE AND SAFE DRUG WITH THE HELP OF OBSERVATIONAL STUDIES
by: S. Y. Martsevich, et al.
Published: (2017-05-01)